Menu
1 min read · estimated
APPROVED USE
What FDA approved
For adults with advanced ovarian cancer in the initial combination treatment setting, and as a single agent for recurrent ovarian cancer after prior chemotherapy.
LAMPGEN ANALYSIS
Why it matters
A separate carboplatin injection presentation supports established advanced and recurrent ovarian cancer indications.
What research teams should watch
Verify vial strength, renal function and target exposure for dose calculation, and the pharmacy’s specific preparation instructions.
PRIMARY RECORDS